NEMP2
geneOn this page
Summary
NEMP2 (nuclear envelope integral membrane protein 2, HGNC:33700) is a protein-coding gene on chromosome 2q32.2, encoding Nuclear envelope integral membrane protein 2 (A6NFY4).
Predicted to be located in nuclear inner membrane. Predicted to be active in nuclear envelope.
Source: NCBI Gene 100131211 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 59 total
- MANE Select transcript:
NM_001142645
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33700 |
| Approved symbol | NEMP2 |
| Name | nuclear envelope integral membrane protein 2 |
| Location | 2q32.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000189362 |
| Ensembl biotype | protein_coding |
| OMIM | 616497 |
| Entrez | 100131211 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 3 nonsense_mediated_decay, 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000343105, ENST00000409150, ENST00000414176, ENST00000421038, ENST00000444545, ENST00000492292, ENST00000920104
RefSeq mRNA: 1 — MANE Select: NM_001142645
NM_001142645
CCDS: CCDS46476
Canonical transcript exons
ENST00000409150 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001577969 | 190510361 | 190510537 |
| ENSE00001586718 | 190534559 | 190534722 |
| ENSE00001630404 | 190504338 | 190509312 |
| ENSE00003464670 | 190514453 | 190514678 |
| ENSE00003505680 | 190518736 | 190518808 |
| ENSE00003549854 | 190517520 | 190517613 |
| ENSE00003551066 | 190525263 | 190525378 |
| ENSE00003619096 | 190518952 | 190519183 |
| ENSE00003692343 | 190516270 | 190516384 |
Expression profiles
Bgee: expression breadth ubiquitous, 174 present calls, max score 84.06.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 5.8931 / max 95.4385, expressed in 1652 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 32903 | 4.9974 | 1621 |
| 32900 | 0.3052 | 133 |
| 32902 | 0.2292 | 103 |
| 32901 | 0.2166 | 91 |
| 32899 | 0.1448 | 61 |
Top tissues by expression
227 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.06 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 82.16 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.60 | gold quality |
| ventricular zone | UBERON:0003053 | 79.72 | gold quality |
| medial globus pallidus | UBERON:0002477 | 78.08 | gold quality |
| tendon | UBERON:0000043 | 77.99 | gold quality |
| calcaneal tendon | UBERON:0003701 | 77.86 | gold quality |
| stromal cell of endometrium | CL:0002255 | 77.80 | gold quality |
| oocyte | CL:0000023 | 77.19 | silver quality |
| bone marrow cell | CL:0002092 | 76.85 | gold quality |
| ganglionic eminence | UBERON:0004023 | 76.55 | gold quality |
| popliteal artery | UBERON:0002250 | 76.12 | gold quality |
| tibial artery | UBERON:0007610 | 76.12 | gold quality |
| adrenal tissue | UBERON:0018303 | 76.00 | gold quality |
| lymph node | UBERON:0000029 | 75.89 | gold quality |
| vermiform appendix | UBERON:0001154 | 75.13 | gold quality |
| globus pallidus | UBERON:0001875 | 74.25 | silver quality |
| aorta | UBERON:0000947 | 73.60 | gold quality |
| right coronary artery | UBERON:0001625 | 73.59 | gold quality |
| leukocyte | CL:0000738 | 73.42 | gold quality |
| endothelial cell | CL:0000115 | 73.35 | gold quality |
| left coronary artery | UBERON:0001626 | 73.07 | gold quality |
| monocyte | CL:0000576 | 73.04 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 73.04 | gold quality |
| testis | UBERON:0000473 | 72.63 | gold quality |
| left testis | UBERON:0004533 | 72.41 | gold quality |
| coronary artery | UBERON:0001621 | 72.33 | gold quality |
| secondary oocyte | CL:0000655 | 72.32 | silver quality |
| descending thoracic aorta | UBERON:0002345 | 72.01 | gold quality |
| gall bladder | UBERON:0002110 | 71.90 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 4.15 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
101 targeting NEMP2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-22-3P | 99.93 | 68.13 | 917 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | nemp2 | ENSDARG00000061062 |
| mus_musculus | Nemp2 | ENSMUSG00000043015 |
| rattus_norvegicus | Nemp2 | ENSRNOG00000012924 |
| drosophila_melanogaster | Nemp | FBGN0030768 |
| caenorhabditis_elegans | WBGENE00017328 |
Paralogs (1): NEMP1 (ENSG00000166881)
Protein
Protein identifiers
Nuclear envelope integral membrane protein 2 — A6NFY4 (reviewed: A6NFY4)
All UniProt accessions (4): A6NFY4, C9J4F2, F8VWJ7, H7C232
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Nucleus inner membrane.
Similarity. Belongs to the NEMP family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A6NFY4-1 | 1 | yes |
| A6NFY4-2 | 2 |
RefSeq proteins (1): NP_001136117* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019358 | NEMP_fam | Family |
Pfam: PF10225
UniProt features (10 total): transmembrane region 5, splice variant 3, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NFY4-F1 | 80.21 | 0.22 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 71 (showing top):
GOCC_NUCLEAR_ENVELOPE, HOWLIN_CITED1_TARGETS_1_UP, GOCC_ORGANELLE_INNER_MEMBRANE, MARSON_BOUND_BY_E2F4_UNSTIMULATED, GOCC_NUCLEAR_INNER_MEMBRANE, GOCC_NUCLEAR_MEMBRANE, GOCC_ORGANELLE_ENVELOPE, DLX6_TARGET_GENES, FOXD2_TARGET_GENES, RLF_TARGET_GENES, SFMBT1_TARGET_GENES, SKIL_TARGET_GENES, ZNF282_TARGET_GENES, ZNF407_TARGET_GENES, ZNF618_TARGET_GENES
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (4): nuclear envelope (GO:0005635), nuclear inner membrane (GO:0005637), nucleus (GO:0005634), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| nucleus | 1 |
| endomembrane system | 1 |
| organelle envelope | 1 |
| organelle inner membrane | 1 |
| nuclear membrane | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
228 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NEMP2 | ANKAR | Q7Z5J8 | 661 |
| NEMP2 | OSGEPL1 | Q9H4B0 | 541 |
| NEMP2 | DIRC1 | Q969H9 | 526 |
| NEMP2 | MFSD6 | Q6ZSS7 | 526 |
| NEMP2 | HIBCH | Q6NVY1 | 507 |
| NEMP2 | ORMDL1 | Q9P0S3 | 479 |
| NEMP2 | PHGR1 | C9JFL3 | 475 |
| NEMP2 | BANF1 | O75531 | 435 |
| NEMP2 | INPP1 | P49441 | 432 |
| NEMP2 | NAB1 | Q13506 | 413 |
| NEMP2 | WDR75 | Q8IWA0 | 376 |
| NEMP2 | ZMAT1 | Q5H9K5 | 373 |
| NEMP2 | AKAP19 | P0C876 | 370 |
| NEMP2 | CLEC12B | Q2HXU8 | 359 |
| NEMP2 | MAST3 | O60307 | 348 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| RAN | NEMP2 | psi-mi:“MI:0914”(association) | 0.530 |
| CHRNA4 | TMEM223 | psi-mi:“MI:0914”(association) | 0.350 |
| NIPAL3 | ILVBL | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (5): TMEM194B (Affinity Capture-MS), TMEM194B (Affinity Capture-RNA), TMEM194B (Affinity Capture-MS), TMEM194B (Affinity Capture-MS), TMEM194B (Affinity Capture-MS)
ESM2 similar proteins: A6NFY4, A6QNT4, A7MBC7, D3Z291, D3ZEH5, O14524, P0C8N6, P50747, P51811, P60570, Q2HJ63, Q2HJB9, Q3TD49, Q49LS5, Q49LS8, Q5F383, Q5GH61, Q5JZQ8, Q5PQL3, Q5RDB4, Q5RJQ8, Q5XII8, Q5ZJY9, Q5ZKY0, Q60GF7, Q6AXN4, Q6AYS5, Q6ZQE4, Q7SYC7, Q80UF9, Q811Q0, Q8C561, Q8CB65, Q8CHQ0, Q8CIF6, Q8K2I9, Q8NFZ0, Q8TCT8, Q8VEC4, Q90YH8
Diamond homologs: A1L3G9, A6NFY4, A7MBC7, B9X187, E7FE40, F1QYC4, O14524, P0C8N6, Q19293, Q28EH9, Q5RDB4, Q5ZJY9, Q6ZQE4, Q8CB65, Q9VXD6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
59 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 46 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1544 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:190509152:T:TA | donor_gain | 1.0000 |
| 2:190510359:A:AC | donor_gain | 1.0000 |
| 2:190510360:C:CC | donor_gain | 1.0000 |
| 2:190518814:G:GC | acceptor_gain | 1.0000 |
| 2:190518945:GACTT:G | donor_loss | 1.0000 |
| 2:190518946:ACTTA:A | donor_loss | 1.0000 |
| 2:190518948:TTA:T | donor_loss | 1.0000 |
| 2:190518949:TACTG:T | donor_loss | 1.0000 |
| 2:190518950:A:AC | donor_gain | 1.0000 |
| 2:190518950:A:C | donor_loss | 1.0000 |
| 2:190518951:C:CA | donor_gain | 1.0000 |
| 2:190518951:C:T | donor_loss | 1.0000 |
| 2:190518951:CT:C | donor_gain | 1.0000 |
| 2:190518951:CTG:C | donor_gain | 1.0000 |
| 2:190518951:CTGTT:C | donor_gain | 1.0000 |
| 2:190509153:C:A | donor_gain | 0.9900 |
| 2:190510354:GACTT:G | donor_loss | 0.9900 |
| 2:190510355:ACTT:A | donor_loss | 0.9900 |
| 2:190510356:CTTA:C | donor_loss | 0.9900 |
| 2:190510357:TTA:T | donor_loss | 0.9900 |
| 2:190510358:TA:T | donor_loss | 0.9900 |
| 2:190510359:ACT:A | donor_loss | 0.9900 |
| 2:190510360:C:G | donor_loss | 0.9900 |
| 2:190510360:CTTG:C | donor_gain | 0.9900 |
| 2:190514452:CCA:C | donor_gain | 0.9900 |
| 2:190514633:T:C | acceptor_gain | 0.9900 |
| 2:190517611:CTT:C | acceptor_gain | 0.9900 |
| 2:190517614:C:CC | acceptor_gain | 0.9900 |
| 2:190518734:A:AC | donor_gain | 0.9900 |
| 2:190518735:C:CT | donor_gain | 0.9900 |
AlphaMissense
2727 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:190514650:G:C | S252R | 0.992 |
| 2:190514650:G:T | S252R | 0.992 |
| 2:190514652:T:G | S252R | 0.992 |
| 2:190509300:A:C | F381L | 0.984 |
| 2:190509300:A:T | F381L | 0.984 |
| 2:190509302:A:G | F381L | 0.984 |
| 2:190510395:A:G | W366R | 0.976 |
| 2:190510395:A:T | W366R | 0.976 |
| 2:190516354:A:G | C215R | 0.972 |
| 2:190525277:A:G | W67R | 0.969 |
| 2:190525277:A:T | W67R | 0.969 |
| 2:190509301:A:G | F381S | 0.966 |
| 2:190509298:A:T | V382D | 0.965 |
| 2:190510430:A:G | L354P | 0.965 |
| 2:190509301:A:C | F381C | 0.962 |
| 2:190516351:A:G | W216R | 0.962 |
| 2:190516351:A:T | W216R | 0.962 |
| 2:190510393:C:A | W366C | 0.956 |
| 2:190510393:C:G | W366C | 0.956 |
| 2:190514661:C:G | G249R | 0.955 |
| 2:190514661:C:T | G249R | 0.955 |
| 2:190510427:C:G | R355P | 0.954 |
| 2:190509310:A:G | F378S | 0.953 |
| 2:190519169:A:C | S76R | 0.949 |
| 2:190519169:A:T | S76R | 0.949 |
| 2:190519171:T:G | S76R | 0.949 |
| 2:190517576:C:G | G186R | 0.948 |
| 2:190516373:A:C | F208L | 0.947 |
| 2:190516373:A:T | F208L | 0.947 |
| 2:190516375:A:G | F208L | 0.947 |
dbSNP variants (sampled 300 via entrez): RS1000018158 (2:190499584 C>G), RS1000023906 (2:190546697 T>A), RS1000026890 (2:190460331 T>A), RS1000058512 (2:190517930 A>C), RS1000067459 (2:190647508 CTT>C), RS1000078690 (2:190460536 T>C), RS1000088689 (2:190499208 A>G), RS1000091584 (2:190586391 C>G), RS1000092279 (2:190492028 C>A,G,T), RS1000093194 (2:190647805 C>T), RS1000093869 (2:190552232 A>T), RS1000146913 (2:190426559 T>C), RS1000163178 (2:190500635 G>A), RS1000166944 (2:190486775 AT>A), RS1000170866 (2:190506636 T>C)
Disease associations
OMIM: gene MIM:616497 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003518_14 | Daytime sleep phenotypes | 3.000000e-06 |
| GCST004280_83 | Diastolic blood pressure | 1.000000e-11 |
| GCST007094_193 | Diastolic blood pressure | 2.000000e-06 |
| GCST007095_1 | Systolic blood pressure | 9.000000e-06 |
| GCST007095_94 | Systolic blood pressure | 3.000000e-07 |
| GCST007096_38 | Pulse pressure | 1.000000e-10 |
| GCST007097_55 | Pulse pressure | 3.000000e-06 |
| GCST007097_56 | Pulse pressure | 1.000000e-06 |
| GCST007099_203 | Systolic blood pressure | 5.000000e-13 |
| GCST011096_35 | Systemic lupus erythematosus | 1.000000e-13 |
| GCST011097_1 | Systemic lupus erythematosus | 7.000000e-09 |
| GCST90011866_10 | Systemic lupus erythematosus | 3.000000e-06 |
| GCST90014033_20 | Haemorrhoidal disease | 2.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007828 | daytime rest measurement |
| EFO:0006336 | diastolic blood pressure |
| EFO:0006335 | systolic blood pressure |
| EFO:0005763 | pulse pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
16 total (human), top 16 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Particulate Matter | increases abundance, increases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| GSK-J4 | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| sodium arsenite | decreases expression | 1 |
| butyraldehyde | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Aflatoxin M1 | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): hemorrhoid